Clinical Trials Browser

Phase 2 × OTHER × Recurrent Bladder Urothelial Carcinoma × Clear all

NCT02718742 2016-04-18

Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer

Phase 2 Withdrawn

Recurrent Bladder Urothelial Carcinoma